ReviewCancers2023

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations.

Ilaria Attili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.